- About
- PsychU For You
- Topics
- Events
- Content
Major Depressive Disorder In Chronic Kidney Disease
About This Event
Major Depressive Disorder In Chronic Kidney Disease
Major Depressive Disorder affects more than 260 million people worldwide1. The reported prevalence of depression in patients with Chronic Kidney Disease (CKD) ranges from 20-65%2. This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology.
Resources:
1. World Health Organization. Fact Sheet on Depression. (2012) https://www.who.int/health-topics/depression#tab=tab_1
2. Teles F et al. Clinics (Sao Paulo). 2014 ;69(3):198-202.Mastro’s Steakhouse – Costa Mesa, CA
Christine Costa, Ph.D., DNP, RN, PMHNP-BC
Psychiatric Nurse practitioner, Gateways Hospital and Mental Health Center
MoreDr. Costa is a psychiatric nurse practitioner with over 20 years of experience in the health field, currently working for Gateways Hospital and Mental Health Center. She serves as an Associate Professor at California State University, Long Beach School of Nursing. Costa received her Doctor of Philosophy from William Carey University in Hattiesburg, Mississippi, and a Doctor of Nursing Practice from Brandman University in Irvine, California.
Rebecca Ahdoot, MD, FASN, MD, FASN
Assistant Professor — Department of Nephrology Director – PKD Partner Clinic at the UCI School of Medicine*
MoreDr Rebecca S. Ahdoot is a board-certified UCI Health nephrologist and director of the PKD Partner Clinic at UCI. She specializes in the management of acute and chronic kidney disease, hypertension/high blood pressure, kidney stones, electrolyte abnormalities and dialysis. She earned her medical degree at the UCI School of Medicine and completed an internal medicine residency at Kaiser Permanente Los Angeles Medical Center. She completed a joint neurology fellowship with Kaiser Permanente and Cedars-Sinai in Los Angeles. She also completed the UCLA Kennamer/Kaiser Permanente Community Medicine Fellowship program, which focuses on healthcare policy, patient advocacy and primary care. Dr Ahdoot is passionate about community service and outreach. She founded a bi-annual health fair to address the lack of affordable, timely vision and hearing services for low-income patients. She also has participated in volunteer medical missions to Guatemala through HELPS International.
Marla Dallal, PharmD, RPH
Clinical & Scientific Liaison (Nephrology)
MoreMarla Dallal, PharmD, RPH is a Clinical & Scientific Liaison at Otsuka Pharmaceutical Development and Commercialization covering Southern California. She earned her Doctor of Pharmacy degree from the University of Southern California, School of Pharmacy in Los Angeles. While in pharmacy school, Dr Dallal pursued various clinical internships within the acute care and ambulatory care settings at Cedars-Sinai Medical Center and Kaiser Permanente. Prior to joining Otsuka, Dr Dallal held various positions within Medical Affairs at Amgen Inc covering the cardiometabolic and nephrology therapeutic areas. She also served as a preceptor at Amgen Inc, where she instructed pharmacy students on Advanced Pharmacy Practice rotations. She is currently licensed as a pharmacist in the state of California with the National Association Board of Pharmacy.
Elika Hefazi, PharmD, BCPP (OPDC)
Medical Science Liaison
Speakers Christine Costa, Ph.D., DNP, RN, PMHNP-BC, PhD, DNP, RN, PMHNP-BC and Rebecca S. Ahdoot MD, FASN, MD, FASN are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).
Speakers Elika Hefazi, PharmD, BCPP, PharmD, BCPP and Marla Dallal, PharmD, RPH are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).Related Events
Registration
PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS
PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.
PSYCHU MEMBERSHIP ELIGIBILITY
In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients. NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.
MEMBERSHIP & REGISTRATION
Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.
ATTENDANCE LIMITATIONS
PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.
MEAL REPORTING
The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.
- PsychU For You
